ASTA Co., Ltd.

246720 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩6,070.00
+0.00%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.51.
  • Current assets comfortably cover current liabilities (current ratio 7.15).
  • Sales have compounded about 39% a year over five years.

!Watch-points

  • Thin interest cover: operating profit covers interest only about -16 times.
  • Return on equity is on the lower side at -38.7%.
  • Return on capital employed is on the lower side at -28.3%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-4.96

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩994억
Current Price₩ 6,070.00
High / Low₩ 11,080.00 / 5,900.00
Stock P/E-27.47
Book Value₩ 560.84
ROCE-28.26%
ROE-38.68%
Debt to Equity0.51
Current Ratio7.15
EPS₩ -221.00
PAT Margin-83.68%
ICR-15.95
Compounded Sales Growth
10 Years
5 Years 38.81%
3 Years 30.48%
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year -38.68%
Educational data only. Not a recommendation to buy, sell or hold any security.